glp-1 receptor agonist mechanism of action Frontiers The GLP-1 Agonists and Obesity:

Ed Charbonneau of Valparaiso and Justin Busch of Fort Wayne, would require compound pharmacies that develop GLP-1 weight-loss drugs to comply with provisions of the Food, Drug and Cosmetic Act, such as that the drugs must be developed by a state-licensed pharmacist and that the Indiana Board of Pharmacy would investigate and enforce compliance by compound pharmacies

Barber AJ

Los resultados de estudios experimentales han sugerido que dosis farmacolgicas de citicolina (CDP-colina) podran mejorar el metabolismo de la glucosa y la biosntesis de fosfolpidos y neurotransmisores, al tiempo que limitan la degradacin de los fosfolpidos en las membranas neuronales en modelos de isquemia y enfermedades neurodegenerativas (revisado en 92)

Chakrapani, H